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BACKGROUND: Lower urinary tract symptoms related to benign prostatic obstruction
(BPO) are frequent in men aged > 50 years. Based on the use of innovative medical
devices, a number of transurethral ablative techniques have recently been developed
for the surgical treatment of BPO. In recent years, GreenLight photoselective
vaporization of the prostate (PVP) has been considered as a non-inferior alternative to
transurethral resection of the prostate. The GreenLight PVP is usually considered as
an interesting surgical option for patients treated via oral anticoagulants (OACs) with
regard to its haemostatic properties. The aim of this study was to assess the impact of
maintaining OAC treatment in patients undergoing PVP.
METHODS: This study is a multicentre, open-label, randomized controlled trial (RCT)
designed to show the non-inferiority of PVP surgery in patients with BPO treated with
OACs. This study is designed to enrol 386 OAC-treated patients (treated with vitamin K
antagonists and direct oral anticoagulants) who are undergoing PVP for BPO. Patients
will be randomized (1:1) to either maintain or stop OAC treatment during the
perioperative course. The intervention group will maintain OAC treatment until the
day before surgery and resume OAC treatment the day after surgery, whereas the
control group will stop OAC treatment (with or without low-molecular-weight heparin
bridging therapy) according to the anaesthesia guidelines. The primary outcome of
interest to be assessed is the 30-day complications rate according to the Clavien-Dindo
classification. The secondary endpoint will examine the 30-day rate of haemorrhagic
and thrombotic events. This study will provide 80% power to show non-inferiority,
defined as not worse than a 10% (non-inferiority margin) inferior change in the
proportion of patients with good outcomes (Clavien-Dindo score < 2), using two-tailed
95% confidence intervals.
DISCUSSION: This first multicentre RCT in the field is underway to evaluate the safety
and efficacy of PVP in patients with ongoing OAC therapy. The study results could
influence the perioperative management of OACs in BPO surgery with a high level of
evidence.
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